CLDX Celldex Therapeutics, Inc. - Common Stock
$41,97
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$20–$45
87% of range
Ocena Analityków
BUY
22 analysts
Cena Docelowa
$58
+38% upside
P/E (TTM)
-10.8
ROE
-43.8%
Marża Zysku Netto
-16748.0%
CLDX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$41.97
Kapitalizacja Rynkowa
$2.79B
P/E (TTM)
-10.8
EPS (TTM)
$-3.90
Przychody (TTM)
$2M
Stopa dywidendy
—
ROE
-43.8%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$20 – $45
CLDX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$2M
2016-12-31
→
2025-12-31
EPS
$-3.90
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-214M
2016-12-31
→
2025-12-31
Marże
-16748.0%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CLDX
Mediana porównawcza
P/E (TTM)
-10.8
—
P/S (TTM)
1807.6
18.3
P/B
5.3
3.3
Price / FCF (Cena / FCF)
-13.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CLDX
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-18599.8%
—
Net Profit Margin (Marża Zysku Netto)
-16748.0%
-180.4%
ROA
-37.6%
-36.2%
ROE
-43.8%
-43.7%
ROIC
-54.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CLDX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
10.5
9.7
Quick Ratio (Wskaźnik Szybkości)
10.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CLDX
Mediana porównawcza
Revenue YoY (Przychody R/R)
-78.0%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-13.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
-26.9%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CLDX
Mediana porównawcza
CLDX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
22 analityków
- Mocne kupno 7 31,8%
- Kup 13 59,1%
- Trzymaj 2 9,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
15 analityków · 2026-08-14
Mediana
$56.00
Teraz
$41.97
Niski
$38.00
Wysoki
$100.00
Średni cel
$56.00
+33,4%
Średnia cel
$58.07
+38,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.03%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.94 | $-1.08 | 0.14% |
| 31 marca 2026 | $-1.18 | $-1.16 | -0.02% |
| 31 grudnia 2025 | $-1.22 | $-1.03 | -0.19% |
| 30 września 2025 | $-1.01 | $-0.92 | -0.09% |
| 30 czerwca 2025 | $-0.85 | $-0.87 | 0.02% |
| 31 marca 2025 | $-0.81 | $-0.77 | -0.04% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Cost of Revenue | $200.0K | $200.0K | $300.0K | $100.0K | $100.0K | $200.0K | $100.0K | $700.0K | $700.0K | $2M | · | · | |
| R&D Expense | $245M | $164M | $118M | $82M | $53M | $43M | $43M | $66M | $96M | $103M | $100M | $104M | |
| SG&A Expense | $44M | $39M | $31M | $27M | $20M | $14M | $15M | $19M | $25M | $36M | $34M | $21M | |
| Operating Expenses | $289M | $202M | $161M | $118M | $76M | $71M | $59M | $166M | $134M | $140M | $135M | $126M | |
| Operating Income | $-287M | $-195M | $-155M | $-115M | $-71M | $-63M | $-55M | $-156M | $-122M | $-133M | $-130M | $-122M | |
| Pretax Income | $-259M | $-158M | $-141M | $-112M | $-71M | $-61M | $-51M | $-152M | $-117M | $-129M | $-127M | · | |
| Income Tax | $0 | $0 | $0 | · | $-227.0K | $-1M | · | $-765.0K | $-24M | · | · | · | |
| Net Income | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| EPS (Basic) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| EPS (Diluted) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| Shares (Basic) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| Shares (Diluted) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| EBITDA | $-284M | $-192M | $-152M | $-112M | $-68M | $-59M | $-50M | $-153M | $-117M | $-130M | $-127M | $-120M |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $28M | $35M | $29M | $39M | $44M | $11M | $24M | $40M | $42M | $72M | $28M | |
| Short-term Investments | $490M | $697M | $389M | $276M | $369M | $151M | $53M | $70M | · | · | · | · | |
| Prepaid Expense | $14M | $21M | $5M | $12M | $2M | $2M | $1M | $2M | $3M | $4M | $4M | $4M | |
| Current Assets | $535M | $747M | $432M | $318M | $411M | $198M | $67M | $99M | $145M | $196M | $295M | $205M | |
| PP&E (Net) | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $6M | $10M | $13M | $11M | $11M | |
| PP&E (Gross) | $29M | $28M | $26M | $25M | $25M | $25M | $32M | $32M | $34M | $33M | $29M | $25M | |
| Accum. Depreciation | $24M | $23M | $22M | $22M | $21M | $21M | $28M | $26M | $24M | $20M | $17M | $14M | |
| Goodwill | · | · | · | · | · | · | · | · | $91M | $91M | $9M | $9M | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $31M | $49M | $49M | $68M | $81M | $21M | $22M | |
| Other Non-current Assets | $13M | $10M | $107.0K | $104.0K | $104.0K | $41.0K | $41.0K | $2M | $2M | $2M | $1M | $2M | |
| Total Assets | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Accounts Payable | $1M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $47M | $34M | $22M | $13M | $12M | $8M | $6M | $7M | $19M | $29M | $24M | $19M | |
| Current Liabilities | $51M | $40M | $31M | $19M | $17M | $14M | $12M | $13M | $28M | $35M | $30M | $24M | |
| Capital Leases | $784.0K | $2M | $928.0K | $3M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Other Non-current Liabilities | $4M | $3M | $4M | $5M | $7M | $10M | $16M | $19M | $52M | $83M | $17M | $12M | |
| Total Liabilities | $56M | $45M | $36M | $27M | $25M | $26M | $29M | $32M | $79M | $118M | $47M | $36M | |
| Common Stock | $67.0K | $66.0K | $56.0K | $47.0K | $47.0K | $40.0K | $17.0K | $12.0K | $9.0K | $121.0K | $99.0K | $90.0K | |
| Retained Earnings | $-1.81B | $-1.56B | $-1.40B | $-1.26B | $-1.14B | $-1.07B | $-1.01B | $-962M | $-813M | $-719M | $-591M | $-464M | |
| AOCI | $4M | $3M | $3M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stockholders' Equity | $527M | $747M | $429M | $326M | $419M | $209M | $94M | $124M | $236M | $265M | $290M | $212M | |
| Liabilities + Equity | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Shares Outstanding | 66,549,442 | 66,374,549 | 55,883,377 | 47,200,695 | 46,730,198 | 39,603,771 | 16,972,077 | 11,957,635 | 9,234,693 | 120,516,654 | 98,685,595 | 89,592,779 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Stock-based Comp | $36M | $34M | $24M | $16M | $9M | $4M | $5M | $8M | $12M | $15M | $13M | $7M | |
| Amort. of Intangibles | · | · | · | · | · | $0 | $0 | $224.0K | $896.0K | $997.0K | $1M | $1M | |
| Other Non-cash | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-211M | $-158M | $-107M | $-104M | $-61M | $-40M | $-46M | $-75M | $-100M | $-113M | $-99M | $-102M | |
| CapEx | $3M | $2M | $2M | $2M | $1M | $2M | $731.0K | $813.0K | $2M | $3M | $5M | $2M | |
| Investing Cash Flow | $209M | $-290M | $-106M | $90M | $-216M | $-98M | $17M | $30M | $46M | $69M | $-50M | · | |
| Stock Issued | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Net Stock Activity | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Financing Cash Flow | $2M | $441M | $218M | $4M | $272M | $171M | $16M | $29M | $51M | $14M | $193M | · | |
| Net Change in Cash | $515.0K | $-6M | $5M | $-10M | $-5M | $33M | $-13M | $-16M | $-2M | $-30M | $44M | $-141M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-214M | $-160M | $-109M | $-106M | $-62M | $-42M | $-47M | $-76M | $-102M | $-116M | $-104M | $-103M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% | -1540.2% | · | -953.7% | -1958.7% | -2363.9% | -3414.1% | |
| Net Margin | -16748.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -16748.0% | -2248.8% | -2054.8% | -4765.6% | -1520.9% | -821.6% | -1424.0% | · | -920.6% | · | · | · | |
| EBITDA Margin | -18381.0% | -2733.6% | -2201.6% | -4766.1% | -1465.8% | -801.1% | -1404.2% | · | -919.0% | -1913.1% | -2309.2% | -3347.5% | |
| ROA | -37.6% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -43.8% | · | · | · | · | · | · | · | · | · | · | · | |
| ROIC | -54.5% | · | · | · | -16.9% | -29.7% | · | -125.5% | -40.8% | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 | 13.9 | 5.7 | 7.9 | 5.2 | 5.6 | 9.8 | 8.4 | |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 | 13.7 | 5.5 | 1.9 | 1.5 | 1.2 | 2.4 | 1.1 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -78.0% | 2.0% | 192.0% | -49.3% | -37.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -13.1% | 14.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Net Income TTM | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| Market Cap | $1.81B | $1.68B | $2.22B | $2.10B | $1.81B | $694M | $38M | $36M | $5.90B | $6.40B | $23.21B | $24.53B | |
| P/E | -7.0 | -10.3 | -13.6 | -18.6 | -23.6 | -8.7 | -0.6 | · | · | · | · | · | |
| P/S | 1169.9 | 238.9 | 322.0 | 892.5 | 388.2 | 93.5 | 10.6 | 3.8 | 463.1 | 943.0 | 4235.6 | 6839.4 | |
| P/B | 3.4 | 2.2 | 5.2 | 6.4 | 4.3 | 3.3 | 0.4 | 0.3 | 25.0 | 24.1 | 80.0 | 115.9 | |
| P / Tangible Book | 3.6 | 2.3 | 5.5 | 7.0 | 4.6 | 3.9 | · | · | · | · | · | · | |
| P / Cash Flow | -8.6 | -10.6 | -20.7 | -20.3 | -29.6 | -17.2 | -0.8 | -0.5 | -59.1 | -56.6 | -234.7 | -241.5 | |
| P / FCF | -8.5 | -10.5 | -20.3 | -19.9 | -29.0 | -16.5 | -0.8 | -0.5 | -58.0 | -55.3 | -223.7 | -237.0 | |
| Earnings Yield | -14.4% | -9.7% | -7.4% | -5.4% | -4.2% | -11.5% | -157.4% | · | · | · | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.0K | $15.0K | $121.0K | $0 | $730.0K | $695.0K | $1M | $3M | $2M | $156.0K | $2M | $268.0K | $967.0K | $2M | $407.0K | $163.0K | |
| R&D Expense | $68M | $73M | $75M | $63M | $54M | $53M | $47M | $45M | $40M | $32M | $35M | $26M | $27M | $23M | $22M | $21M | |
| SG&A Expense | $13M | $11M | $12M | $11M | $10M | $11M | $10M | $10M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $81M | $84M | $87M | $74M | $65M | $63M | $57M | $55M | $49M | $41M | $43M | $33M | $33M | $29M | $28M | $37M | |
| Operating Income | $-81M | $-84M | $-87M | $-74M | $-64M | $-63M | $-56M | $-52M | $-46M | $-41M | $-41M | $-33M | $-32M | $-28M | $-28M | $-36M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M | $-27M | $-36M | |
| Net Income | $-74M | $-79M | $-81M | $-67M | $-57M | $-54M | $-47M | $-42M | $-36M | $-33M | · | · | · | · | · | · | |
| EPS (Basic) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| EPS (Diluted) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.57 | $-0.77 | |
| Shares (Basic) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| Shares (Diluted) | 77,840,000 | 66,566,000 | 66,222,805 | 66,420 | 66,392,000 | 66,383,000 | 64,203,816 | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | -93,526 | 46,916 | 46,759 | |
| EBITDA | $-81M | · | · | $-74M | $-64M | $-62M | · | $-52M | $-46M | $-40M | $-41M | $-33M | $-32M | · | $-28M | $-36M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $29M | $36M | $23M | $17M | $28M | $36M | $43M | $115M | $21M | $28M | $54M | · | $19M | $28M | |
| Short-term Investments | $670M | $416M | $490M | $547M | $607M | $656M | $697M | $720M | $760M | $709M | $214M | $224M | $224M | · | $305M | $328M | |
| Prepaid Expense | $7M | $8M | $14M | $21M | $18M | $19M | $21M | $22M | $8M | $9M | $10M | $12M | $10M | · | $11M | $11M | |
| Current Assets | $725M | $459M | $535M | $604M | $648M | $694M | $747M | $779M | $812M | $835M | $246M | $265M | $290M | · | $335M | $368M | |
| PP&E (Net) | $10M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | |
| PP&E (Gross) | · | · | $29M | · | · | · | $28M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $24M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | $27M | $27M | |
| Other Non-current Assets | $15M | $15M | $13M | $9M | $9M | $10M | $10M | $10M | $107.0K | $107.0K | $107.0K | $107.0K | $104.0K | · | $104.0K | $104.0K | |
| Total Assets | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Accounts Payable | $15M | $10M | $1M | $4M | $2M | $3M | $3M | $1M | $4M | $3M | $4M | $881.0K | $3M | · | $2M | $902.0K | |
| Accrued Liabilities | $44M | $38M | $47M | $40M | $28M | $25M | $34M | $28M | $19M | $18M | $18M | $12M | $9M | · | $11M | $11M | |
| Current Liabilities | $61M | $51M | $51M | $46M | $33M | $32M | $40M | $32M | $28M | $26M | $28M | $16M | $15M | · | $16M | $30M | |
| Capital Leases | $3M | $443.0K | $784.0K | $1M | $1M | $2M | $2M | $2M | $796.0K | $470.0K | $1M | $2M | $2M | · | $2M | $3M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | · | $5M | $5M | |
| Total Liabilities | $68M | $55M | $56M | $50M | $37M | $36M | $45M | $37M | $32M | $30M | $34M | $22M | $22M | · | $24M | $38M | |
| Common Stock | $79.0K | $67.0K | $67.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $47.0K | $47.0K | $47.0K | · | $47.0K | $47.0K | |
| Retained Earnings | $-1.97B | $-1.89B | $-1.81B | $-1.73B | $-1.67B | $-1.61B | $-1.56B | $-1.51B | $-1.47B | $-1.43B | $-1.35B | $-1.32B | $-1.29B | · | $-1.23B | $-1.20B | |
| AOCI | $1M | $3M | $4M | $4M | $3M | $4M | $3M | $5M | $2M | $2M | $2M | $2M | $2M | · | $-112.0K | $-417.0K | |
| Stockholders' Equity | $715M | $456M | $527M | $598M | $655M | $703M | $747M | $786M | $814M | $839M | $247M | $278M | $303M | $326M | $345M | $365M | |
| Liabilities + Equity | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | · | $369M | $403M | |
| Shares Outstanding | 78,500,173 | 66,568,971 | 66,549,442 | 66,446,846 | 66,394,241 | 66,384,191 | 66,374,549 | 66,344,236 | 66,280,667 | 65,910,548 | 47,264,197 | 47,253,813 | 47,244,681 | · | 47,096,063 | 46,764,703 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $902.0K | $854.0K | $816.0K | $824.0K | $873.0K | $867.0K | $819.0K | $786.0K | $797.0K | $775.0K | $767.0K | $756.0K | $726.0K | $673.0K | $671.0K | $741.0K | |
| Stock-based Comp | $8M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $8M | $7M | $7M | $5M | $4M | $5M | $4M | $3M | |
| Operating Cash Flow | $-57M | $-66M | $-64M | $-49M | $-44M | $-54M | $-32M | $-55M | $-29M | $-41M | $-19M | $-27M | $-29M | $-22M | $-35M | $-22M | |
| CapEx | $3M | $2M | $1M | $440.0K | $728.0K | $265.0K | $756.0K | $545.0K | $274.0K | $344.0K | $157.0K | $410.0K | $585.0K | $235.0K | $345.0K | $673.0K | |
| Investing Cash Flow | $-256M | $72M | $55M | $61M | $50M | $43M | $24M | $48M | $-47M | $-315M | $12M | $1M | $53M | $31M | $23M | $25M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $432M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $432M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $327.0K | $1M | $774.0K | $63.0K | $202.0K | $386.0K | $1M | $4M | $436M | $257.0K | $133.0K | $694.0K | $1M | $2M | $71.0K | |
| Net Change in Cash | $12M | $7M | $-7M | $13M | $6M | $-11M | $-8M | $-6M | $-72M | $80M | $-7M | $-26M | $25M | $11M | $-10M | $3M | |
| Free Cash Flow | · | · | · | · | · | $-55M | · | · | · | $-41M | · | · | $-29M | · | · | · |
Rentowność 6
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -366468.2% | · | · | · | -8747.5% | -9027.2% | · | -1633.5% | -1854.2% | -26030.8% | -2718.5% | -12389.9% | -3357.9% | · | -6804.9% | -22328.8% | |
| Net Margin | -334104.6% | · | · | · | -7753.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -6580.8% | -22088.3% | |
| EBITDA Margin | -366468.2% | · | · | · | -8747.5% | -8902.5% | · | -1633.5% | -1854.2% | -25534.0% | -2718.5% | -12389.9% | -3282.8% | · | -6804.9% | -22328.8% | |
| ROA | -10.0% | · | · | -9.1% | -7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -10.7% | · | · | -9.7% | -7.7% | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | · | 13.0 | 19.7 | 21.7 | · | 24.3 | 29.4 | 31.8 | 8.8 | 16.9 | 19.0 | · | 20.5 | 12.3 | |
| Quick Ratio | 11.7 | · | · | 12.6 | 19.1 | 21.0 | · | 23.6 | 29.0 | 31.3 | 8.5 | 16.2 | 18.3 | · | 19.9 | 11.9 |
Efektywność 1
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $7M | $7M | $7M | · | $7M | $4M | $3M | $3M | $2M | $2M | · | $897.0K | $4M | |
| Net Income TTM | $-276M | $-256M | · | $-220M | $-188M | $-165M | · | · | · | · | · | · | · | · | · | · | |
| Market Cap | $2.92B | · | · | $1.72B | $1.35B | $1.20B | · | $2.26B | $2.45B | $2.77B | $1.30B | $1.60B | $1.70B | · | $1.32B | $1.26B | |
| P/E | -9.3 | -8.2 | · | -7.8 | -7.2 | -7.1 | · | -13.3 | -14.5 | -15.9 | -10.4 | -13.0 | -14.7 | · | -12.3 | -13.2 | |
| P/S | · | · | · | 241.6 | 189.9 | 184.2 | · | 306.3 | 552.6 | 951.3 | 411.7 | 888.3 | 993.5 | · | 1475.9 | 317.6 | |
| P/B | 4.1 | · | · | 2.9 | 2.1 | 1.7 | · | 2.9 | 3.0 | 3.3 | 5.3 | 5.8 | 5.6 | · | 3.8 | 3.5 | |
| P / Tangible Book | 4.2 | 4.9 | · | 3.0 | 2.2 | 1.8 | · | 3.0 | 3.1 | 3.4 | 5.9 | 6.4 | 6.2 | · | 4.2 | 3.7 | |
| P / Cash Flow | · | · | · | · | · | -22.2 | · | · | · | -68.1 | · | · | -59.5 | · | · | · | |
| P / FCF | · | · | · | · | · | -22.1 | · | · | · | -67.5 | · | · | -58.3 | · | · | · | |
| Earnings Yield | -10.7% | -12.1% | · | -12.8% | -14.0% | -14.1% | · | -7.5% | -6.9% | -6.3% | -9.6% | -7.7% | -6.8% | · | -8.1% | -7.6% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $2M | $7M | $7M | $2M | $5M |
| Marża Operacyjna % | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% |
| Zysk netto | $-259M | $-158M | $-141M | — | — |
| Rozwodniony EPS | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 |
| Wskaźnik Szybkości | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-214M | $-160M | $-109M | $-106M | $-62M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 277 emitentów · $2.6B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 62 (+2 vs poprzedni kw.) | 20 (+7 vs poprzedni kw.) | 99 (+31 vs poprzedni kw.) | 56 (+1 vs poprzedni kw.) | +15.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $312 415 309 | 8 396 004 | 12,07% | Akcje |
| Kynam Capital Management, LP | $198 065 407 | 5 322 908 | 7,65% | Akcje |
| STATE STREET CORP | $145 134 889 | 3 900 427 | 5,61% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $128 926 362 | 3 464 831 | 4,98% | Akcje |
| Deep Track Capital, LP | $109 365 809 | 2 939 151 | 4,22% | Akcje |
| VANGUARD GROUP INC | $95 540 813 | 3 517 703 | 3,69% | Akcje |
| FMR LLC | $87 111 215 | 2 341 070 | 3,36% | Akcje |
| Logos Global Management LP | $78 141 000 | 2 100 000 | 3,02% | Akcje |
| Eversept Partners, LP | $66 454 865 | 1 785 941 | 2,57% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $64 373 504 | 1 729 584 | 2,49% | Akcje |
| Commodore Capital LP | $50 233 500 | 1 350 000 | 1,94% | Akcje |
| Bellevue Group AG | $44 652 000 | 1 200 000 | 1,72% | Akcje |
| BAKER BROS. ADVISORS LP | $44 004 955 | 1 182 611 | 1,70% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $43 564 984 | 1 170 787 | 1,68% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $38 787 594 | 1 042 395 | 1,50% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $38 586 770 | 1 037 000 | 1,49% | Akcje |
| NOVO HOLDINGS A/S | $38 140 250 | 1 025 000 | 1,47% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $37 326 505 | 1 003 131 | 1,44% | Akcje |
| Elmind Capital, LP | $36 837 900 | 990 000 | 1,42% | Akcje |
| Driehaus Capital Management LLC | $36 817 137 | 989 442 | 1,42% | Akcje |
| Fisher Asset Management, LLC | $36 677 040 | 985 677 | 1,42% | Akcje |
| Pictet Asset Management Holding SA | $34 136 752 | 917 408 | 1,32% | Akcje |
| Foresite Capital Management VI LLC | $32 734 121 | 879 713 | 1,26% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32 132 175 | 863 536 | 1,24% | Akcje |
| GOLDMAN SACHS GROUP INC | $31 451 827 | 845 252 | 1,21% | Akcje |
| Assenagon Asset Management S.A. | $29 347 378 | 788 696 | 1,13% | Akcje |
| Woodline Partners LP | $26 077 884 | 700 830 | 1,01% | Akcje |
| Affinity Asset Advisors, LLC | $26 047 000 | 700 000 | 1,01% | Akcje |
| Rock Springs Capital Management LP | $26 015 223 | 699 146 | 1,00% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $24 604 554 | 661 235 | 0,95% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24 408 048 | 655 954 | 0,94% | Akcje |
| ALGERT GLOBAL LLC | $24 105 978 | 647 836 | 0,93% | Akcje |
| ADAR1 Capital Management, LLC | $23 053 158 | 619 542 | 0,89% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $21 304 139 | 572 538 | 0,82% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $20 576 125 | 552 973 | 0,79% | Akcje |
| 5AM Venture Management, LLC | $18 503 417 | 497 270 | 0,71% | Akcje |
| FEDERATED HERMES, INC. | $18 340 549 | 492 893 | 0,71% | Akcje |
| Candriam S.C.A. | $17 885 437 | 481 125 | 0,69% | Akcje |
| Ikarian Capital, LLC | $17 804 985 | 478 500 | 0,69% | Akcje |
| BRAIDWELL LP | $16 247 598 | 436 646 | 0,63% | Akcje |
| Redmile Group, LLC | $16 146 200 | 433 921 | 0,62% | Akcje |
| CITIGROUP INC | $14 891 144 | 400 192 | 0,58% | Akcje |
| Palo Alto Investors LP | $14 878 642 | 399 856 | 0,57% | Akcje |
| TSP Capital Management Group, LLC | $13 809 638 | 371 127 | 0,53% | Akcje |
| PFM Health Sciences, LP | $12 753 765 | 342 751 | 0,49% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $12 738 025 | 342 328 | 0,49% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $12 513 388 | 336 291 | 0,48% | Akcje |
| Tetragon Partners GP Ltd | $10 807 310 | 290 441 | 0,42% | Akcje |
| SUPERSTRING CAPITAL MANAGEMENT LP | $10 700 963 | 287 583 | 0,41% | Akcje |
| GordonMD Global Investments LP | $10 408 381 | 279 720 | 0,40% | Akcje |
| BANK OF AMERICA CORP /DE/ | $9 518 951 | 255 817 | 0,37% | Akcje |
| SummitTX Capital, L.P. | $9 487 024 | 254 959 | 0,37% | Akcje |
| SPHERA FUNDS MANAGEMENT LTD. | $8 962 698 | 240 868 | 0,35% | Akcje |
| Rosalind Advisors, Inc. | $7 442 000 | 200 000 | 0,29% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $7 285 273 | 195 788 | 0,28% | Akcje |
| Corient Private Wealth LP | $6 925 155 | 186 110 | 0,27% | Akcje |
| Trexquant Investment LP | $6 866 138 | 184 524 | 0,27% | Akcje |
| Mirador Capital Partners LP | $6 737 019 | 181 054 | 0,26% | Akcje |
| STEMPOINT CAPITAL LP | $6 638 711 | 178 412 | 0,26% | Akcje |
| BlackRock, Inc. | $6 469 963 | 173 877 | 0,25% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 422 446 | 172 600 | 0,25% | Opcja kupna |
| Cinctive Capital Management LP | $5 419 153 | 145 637 | 0,21% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $5 211 781 | 140 064 | 0,20% | Akcje |
| FIRST TRUST ADVISORS LP | $5 160 357 | 138 682 | 0,20% | Akcje |
| Swiss National Bank | $5 023 350 | 135 000 | 0,19% | Akcje |
| MONTANOVA CAPITAL, LLC | $4 513 461 | 121 297 | 0,17% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $4 481 126 | 120 428 | 0,17% | Akcje |
| Point72 Asset Management, L.P. | $4 361 645 | 117 217 | 0,17% | Akcje |
| Ikarian Capital, LLC | $4 241 940 | 114 000 | 0,16% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $3 905 662 | 104 963 | 0,15% | Akcje |
| Propel Bio Management, LLC | $3 858 491 | 103 695 | 0,15% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 754 489 | 100 900 | 0,15% | Opcja sprzedaży |
| Integral Health Asset Management, LLC | $3 721 000 | 100 000 | 0,14% | Akcje |
| DEUTSCHE BANK AG\ | $3 601 705 | 96 794 | 0,14% | Akcje |
| Odyssean, LLC | $3 537 517 | 95 069 | 0,14% | Akcje |
| Caption Management, LLC | $3 348 900 | 90 000 | 0,13% | Opcja sprzedaży |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3 324 267 | 89 338 | 0,13% | Akcje |
| HighVista Strategies LLC | $3 235 930 | 86 964 | 0,12% | Akcje |
| DIADEMA PARTNERS LP | $3 200 060 | 86 000 | 0,12% | Opcja sprzedaży |
| AXA Investment Managers S.A. | $3 138 704 | 121 326 | 0,12% | Akcje |
| Bank of New York Mellon Corp | $3 020 782 | 81 182 | 0,12% | Akcje |
| PDT Partners, LLC | $3 010 252 | 80 899 | 0,12% | Akcje |
| TD Asset Management Inc | $2 951 720 | 79 326 | 0,11% | Akcje |
| ALPS ADVISORS INC | $2 945 730 | 79 165 | 0,11% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $2 811 661 | 88 640 | 0,11% | Akcje |
| XTX Topco Ltd | $2 795 773 | 75 135 | 0,11% | Akcje |
| Seven Fleet Capital Management LP | $2 610 802 | 70 164 | 0,10% | Akcje |
| Birchview Capital, LP | $2 600 979 | 69 900 | 0,10% | Akcje |
| Quantinno Capital Management LP | $2 569 276 | 69 048 | 0,10% | Akcje |
| DAFNA Capital Management LLC | $2 549 555 | 68 518 | 0,10% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 525 864 | 79 630 | 0,10% | Akcje |
| Man Group plc | $2 362 984 | 63 504 | 0,09% | Akcje |
| Rafferty Asset Management, LLC | $2 089 602 | 56 157 | 0,08% | Akcje |
| Caption Management, LLC | $2 072 597 | 55 700 | 0,08% | Akcje |
| Simplify Asset Management Inc. | $1 977 116 | 53 134 | 0,08% | Akcje |
| DIADEMA PARTNERS LP | $1 893 989 | 50 900 | 0,07% | Opcja kupna |
| Burkehill Global Management, LP | $1 860 500 | 50 000 | 0,07% | Akcje |
| SEVEN GRAND MANAGERS, LLC | $1 860 500 | 50 000 | 0,07% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 850 491 | 49 731 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $1 694 060 | 45 527 | 0,07% | Akcje |
Insiderzy spółki 49 insiderów · 19 dyrektorzy generalni · 23 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anthony S Marucci | PRESIDENT & CEO | 25 czerwca 2026 A | 27 231 | 0 | 0 | $0 |
| Una S Ryan | President & CEO | 7 marca 2008 A | 899 213 | 0 | 0 | $0 |
| Samuel Bates Martin | SVP AND CFO | 25 czerwca 2026 A | 24 378 | 0 | 0 | $0 |
| Avery W Catlin | Sr. VP & CFO | 2 września 2016 M | 83 586 | 0 | 0 | $0 |
| Teri L Lawver | SVP & Chief Commercial Officer | 25 czerwca 2026 A | — | 0 | 0 | $0 |
| Freddy A. Jimenez | SVP & GENERAL COUNSEL | 25 czerwca 2026 A | 430 | 0 | 0 | $0 |
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | 25 czerwca 2026 A | 11 247 | 0 | 0 | $0 |
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | 25 czerwca 2026 A | 408 | 0 | 0 | $0 |
| Elizabeth Crowley | SR. VP & CPDO | 25 czerwca 2026 A | 4 726 | 0 | 0 | $0 |
| Diane C. Young | SVP, CHIEF MEDICAL OFFICER | 25 czerwca 2026 A | 2 115 | 0 | 0 | $0 |
| Tibor Keler | EXECUTIVE VP & CSO | 25 czerwca 2026 A | 7 357 | 0 | 0 | $0 |
| Ronald Pepin | SR. VP & CBO | 25 czerwca 2026 A | 20 097 | 0 | 0 | $0 |
| Richard M. Wright | Sr. VP & CCO | 17 czerwca 2021 A | 208 | 0 | 0 | $0 |
| Theresa Lavallee | SVP, Reg.& Precision Medicine | 14 grudnia 2016 A | — | 0 | 0 | $0 |
| Ronald C Newbold | Sr. VP, Business Dev. | 6 stycznia 2009 A | 5 868 | 0 | 0 | $0 |
| Henry C Marsh JR | V.P. Research | 7 marca 2008 M | — | 0 | 0 | $0 |
| Ronald W Ellis | Sr VP R&D | 5 stycznia 2007 A | — | 0 | 0 | $0 |
| Michael E Furlong | Sr. Dir. Bus. Development | 1 lipca 2005 L | 1 500 | 0 | 0 | $0 |
| Alistair Wheeler | V.P. Medical Affairs | 2 stycznia 2004 A | — | 0 | 0 | $0 |
| Denice Torres | Dyrektor | 25 czerwca 2026 A | — | 0 | 0 | $0 |
| Rita Jain | Dyrektor | 25 czerwca 2026 A | — | 0 | 0 | $0 |
| Garry Arthur Neil | Dyrektor | 25 czerwca 2026 A | — | 0 | 0 | $0 |
| Cheryl Cohen | Dyrektor | 25 czerwca 2026 A | — | 0 | 0 | $0 |
| Keith L Brownlie | Dyrektor | 25 czerwca 2026 A | 10 000 | 0 | 0 | $0 |
| Herbert J Conrad | Dyrektor | 25 czerwca 2026 A | 38 500 | 0 | 0 | $0 |
| James J Marino | Dyrektor | 25 czerwca 2026 A | 12 704 | 0 | 0 | $0 |
| Harry Penner JR | Dyrektor | 25 czerwca 2026 A | 41 916 | 0 | 0 | $0 |
| Karen Shoos Lipton | Dyrektor | 17 czerwca 2021 A | 41 833 | 0 | 0 | $0 |
| Gerald Mcmahon PhD | Dyrektor | 3 grudnia 2018 F | 180 697 | 0 | 0 | $0 |
| Larry Ellberger | Dyrektor | 13 czerwca 2018 A | 73 500 | 0 | 0 | $0 |
| Richard Van Den Broek | Dyrektor | 8 czerwca 2016 A | 233 500 | 0 | 0 | $0 |
| Timothy M Shannon | Dyrektor | 4 czerwca 2014 A | 83 212 | 0 | 0 | $0 |
| Rajesh R Parekh | Dyrektor | 22 września 2010 A | 2 000 | 0 | 0 | $0 |
| Charles R Schaller | Dyrektor | 9 września 2010 P | 5 000 | 0 | 0 | $0 |
| Alf A Lindberg | Dyrektor | 24 maja 2007 A | — | 0 | 0 | $0 |
| Francis R Cano | Dyrektor | 24 maja 2007 A | — | 0 | 0 | $0 |
| Peter A Sears | Dyrektor | 24 maja 2007 A | 72 739 | 0 | 0 | $0 |
| Barrie J Ward | Dyrektor | 25 maja 2006 A | 367 915 | 0 | 0 | $0 |
| PDI INC | Dyrektor | 26 maja 2005 A | — | 0 | 0 | $0 |
| Frederick W Kyle | Dyrektor | 13 maja 2004 C | 7 000 | 0 | 0 | $0 |
| MEDAREX INC | Posiadacz 10% | 24 czerwca 2009 S | 2 960 848 | 0 | 0 | $0 |
| Lorantis Holdings LTD | Posiadacz 10% | 7 kwietnia 2008 J | 0 | 0 | 0 | $0 |
| Thomas Andrew Davis | — | 15 czerwca 2017 A | 1 011 | 0 | 0 | $0 |
| George Elston | — | 8 czerwca 2016 A | 28 500 | 0 | 0 | $0 |
| Taha Keilani | — | 7 marca 2008 A | 2 000 | 0 | 0 | $0 |
| Paula R Freeman | — | 7 marca 2008 M | 2 955 | 0 | 0 | $0 |
| Michael Timothy Cooke | — | 5 stycznia 2007 A | — | 0 | 0 | $0 |
| Mary Nicholson | — | 3 stycznia 2005 A | 500 | 0 | 0 | $0 |
| Anthony Helstosky | — | 6 stycznia 2004 C | 6 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Medarex, Inc. I.R.S. Employer Identification Number ×3 zgłoszenia | 26 czerwca 2009 | — | Pierwotne zgłoszenie | — | SEC |
| Lorantis Holdings Limited ×2 zgłoszenia | 12 maja 2008 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 50 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1,33% | 68 615 NS | 31 maja 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,88% | 10 032 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,44% | 70 017 NS | 30 kwietnia 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,23% | 3 856 NS | 31 maja 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,23% | 73 629 NS | 30 kwietnia 2026 | N-PORT |
| IWO · iShares Trust | 0,16% | 576 359 SH | 8 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,16% | 62 064 NS | 30 kwietnia 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,14% | 67 853 SH | 8 sierpnia 2026 | Dziennie |
| FFSM · FIDELITY COVINGTON TRUST | 0,13% | 51 835 NS | 30 kwietnia 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,12% | 43 658 NS | 30 kwietnia 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 8 106 SH | 8 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 24 795 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,10% | 1 997 393 SH | 8 sierpnia 2026 | Dziennie |
| SMMV · iShares Trust | 0,09% | 6 577 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 449 534 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,08% | 14 142 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,08% | 32 806 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 51 058 SH | 8 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,06% | 44 111 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,06% | 3 561 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 368 761 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,05% | 204 021 NS | 30 kwietnia 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 6 865 NS | 30 kwietnia 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 2 846 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 12 901 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,04% | 201 834 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,04% | 137 013 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 30 973 NS | 30 kwietnia 2026 | N-PORT |
| UWM · ProShares Trust | 0,04% | 2 786 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 897 276 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,03% | 4 615 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,03% | 2 818 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 6 539 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2 668 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 71 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 7 780 NS | 30 kwietnia 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26 307 NS | 31 maja 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4 620 NS | 30 kwietnia 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 753 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 79 390 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 117 267 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 22 367 SH | 8 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 15 559 NS | 30 kwietnia 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2 758 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 45 244 NS | 31 maja 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 14 544 NS | 30 kwietnia 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 500 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 636 NS | 31 maja 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 488 906 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6 489 SH | 8 sierpnia 2026 | Dziennie |